Skip to main content

SHORT READS: Oct 1, 2002


Victor Solovyev joins bioinformatics company Softberry as chief scientific officer and will work particularly on methods for predicting alternative gene variants and protein structure. Solovyev was formerly bioinformatics director at Eos Biotechnology and leader of the computational genomics group at the Sanger Centre.


EraGen Biosciences announces that Samraat Raha is its new chief business officer. Raha comes to EraGen from Incyte Genomics, where he was vice president of discovery services.


Barbara Wells is the new CEO of genomics-based forestry company ArborGen in Summerville, SC. Wells comes from Emergent Genetics and previously spent 17 years at Monsanto.


Brian Zambrowicz is climbing the ranks. The former SVP of genomics at Lexicon Genetics, he is now executive vice president of research and will manage the company’s genomic discovery research and alliances.


Michael Savage, best known for leading Molecular Simulations and Pharmacopeia, has been selected as chairman of the board for Blackstone Computing. Savage is expected to help guide the company in its quest to become a major player in the life sciences informatics field.


Ted Slater, formerly director of bioinformatics at Paradigm Genetics, joins Cambridge, Mass.-based startup Genstruct as vice president.


Thomas Colatsky joins Paradigm Genetics as vice president for healthcare research. He was most recently president and CEO of Argolyn Bioscience and also worked at Physiome Sciences and Wyeth-Ayerst.


Frank White heads to IBM Life Sciences as alliance program manager. White was previously director of business development at InforMax.


California’s Large Scale Biology appoints Charles Nash to its board of directors to succeed Leigh Anderson, who resigned.


Syrrx, based in San Diego, hires two senior-level chemists to help its drug-discovery business. Jeffrey Stanford, who comes from GlaxoSmithKline, is senior director of chemistry. Daniel Kassel will be senior director of analytical technologies, and he was previously with DuPont Pharmaceuticals Research Labs.


Brian Lightbody joins Massachusetts-based biopharm Arradial as vice president of business development. Lightbody hails from Zymark and has been chairman for the International Symposium for Laboratory Automation and Robotics since 1997.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.